SACCARDI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.930
EU - Europa 2.445
AS - Asia 1.998
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 100
AF - Africa 80
OC - Oceania 18
Totale 8.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.842
RU - Federazione Russa 1.003
SG - Singapore 589
IT - Italia 583
CN - Cina 523
HK - Hong Kong 236
IE - Irlanda 220
BR - Brasile 180
VN - Vietnam 174
KR - Corea 164
SE - Svezia 162
PL - Polonia 97
IN - India 90
FR - Francia 85
DE - Germania 71
FI - Finlandia 63
CA - Canada 51
GB - Regno Unito 51
JO - Giordania 43
BD - Bangladesh 41
CH - Svizzera 39
JP - Giappone 32
IR - Iran 23
ES - Italia 20
ID - Indonesia 20
MX - Messico 18
AR - Argentina 17
AU - Australia 17
EC - Ecuador 14
EG - Egitto 14
NL - Olanda 14
CI - Costa d'Avorio 13
MA - Marocco 13
TR - Turchia 13
CO - Colombia 11
NG - Nigeria 11
ZA - Sudafrica 10
KE - Kenya 9
UA - Ucraina 9
IQ - Iraq 7
PH - Filippine 7
UZ - Uzbekistan 6
CR - Costa Rica 5
PK - Pakistan 5
AZ - Azerbaigian 4
BE - Belgio 4
DZ - Algeria 4
HN - Honduras 4
AT - Austria 3
EE - Estonia 3
JM - Giamaica 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
SA - Arabia Saudita 3
BJ - Benin 2
CL - Cile 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LI - Liechtenstein 2
NP - Nepal 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MQ - Martinica 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 8.699
Salva come PNG Salva come JPEG
Città #
Santa Clara 897
Ashburn 513
Singapore 437
Dublin 220
Hong Kong 204
Fairfield 191
Chandler 184
San Jose 179
Seoul 163
Milan 161
Hefei 110
Beijing 108
Warsaw 95
Woodbridge 84
Los Angeles 77
Altamura 71
Council Bluffs 71
Lawrence 71
Seattle 71
Cambridge 69
Wilmington 67
Ho Chi Minh City 62
Houston 59
Florence 55
Mumbai 52
Buffalo 51
Lauterbourg 49
Dallas 48
Ann Arbor 47
Kent 46
Rome 46
Boston 44
Princeton 44
Munich 43
The Dalles 38
Hanoi 37
New York 37
Bern 35
Tokyo 32
Moscow 27
Helsinki 24
Clifton 23
Turku 23
São Paulo 22
Chicago 21
Phoenix 21
Dearborn 19
Shanghai 19
Paris 18
Guangzhou 15
Melbourne 15
Montreal 15
Frankfurt am Main 14
Medford 14
Abidjan 13
Brooklyn 13
Jakarta 13
San Diego 13
Da Nang 12
Abuja 11
Boardman 11
Palermo 11
Redondo Beach 11
Casablanca 10
Chennai 10
Orem 10
Toronto 10
Turin 10
Atlanta 9
Bologna 9
Cairo 9
Denver 9
Falls Church 9
Barcelona 8
Lappeenranta 8
Naples 8
Yubileyny 8
Bengaluru 7
London 7
Norwalk 7
Biên Hòa 6
Genoa 6
Johannesburg 6
Venice 6
Washington 6
Curitiba 5
Dhaka 5
Figino 5
Haiphong 5
Jacksonville 5
Manchester 5
Miano 5
Nairobi 5
Ottawa 5
Philadelphia 5
Pune 5
Rio de Janeiro 5
Shenzhen 5
Tehran 5
Thái Bình 5
Totale 5.519
Salva come PNG Salva come JPEG
Nome #
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells 271
Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia ― The scelta trial 260
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects 237
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 232
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 209
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 209
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 207
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 205
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 203
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 200
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 200
MSCs seeded on bioengineered scaffolds improve skin wound healing in rats. 196
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 192
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 186
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 186
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 183
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 180
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 178
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 176
Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium. 175
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 171
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 171
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 167
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 165
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 161
The effects of Exendin-4 on bone marrow-derived mesenchymal cells. 158
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 154
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience 154
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 150
CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis 150
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 150
Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis 145
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 145
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT 145
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update 143
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 140
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology 139
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 139
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 138
GENE EXPRESSION ANALYSIS OF PBMNC FROM MS PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) 134
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis 133
Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. 132
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor 127
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 127
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 127
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 125
DIFFERENCES IN MSCS IP-10 PRODUCTION BETWEEN MS PATIENTS AND HEALTHY DONORS 123
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 121
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 118
The role of chemotherapy in hematopoietic stem cell transplantation for autoimmune disorders: From lymphoablative to myeloablative conditioning protocols 117
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis? 109
Panel Session Report: Multiple Sclerosis 105
Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS 98
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation 93
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party 40
Totale 8.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022233 0 0 0 24 17 5 8 32 15 6 42 84
2022/2023899 57 197 61 35 60 142 117 61 92 0 35 42
2023/2024472 10 61 50 31 38 57 22 85 9 29 52 28
2024/20252.708 120 290 171 463 698 393 55 126 114 49 98 131
2025/20263.057 361 437 284 268 341 109 317 114 167 185 111 363
2026/2027561 119 98 234 110 0 0 0 0 0 0 0 0
Totale 8.799